Opioid Policies

collage

Much like the rest of the United States, residents of the District of Columbia are struggling with substance use disorder (SUD) rate increases and high rates of opioid-related deaths. Unfortunately, these are multi-faceted issues that require year-long initiatives and systematic programs to address the myriad causes of addiction.

MSDC stands as a partner to the District government and private entities to help arrest the rates of opioid and substance abuse in the District. Through our advocacy for better prescribing practices, education on addiction, and even helping our own community through our Physician Health Program, MSDC is working to make DC a leader in reducing SUD, OUD, and addiction.

On a related note, MSDC is passionate about helping patients make prescriptions and medication more affordable. Whether expanding access to biosimilars or advocating for more affordable co-pays, MSDC wants to help our patients afford the medications they need.

MSDC Statement and Testimony on Opioid and Prescription Issues

25th Council information coming soon

 

DC Physicians Prior Auth Push Gets Response

Mar 15, 2023, 10:20 AM by MSDC Staff
Physician letter asking for a prior authorization reform hearing led to almost immediate results.

 

On Monday, DC physicians sent a letter to the Committee on Health asking for a hearing on DC's prior auth legislation.

Since then, MSDC has heard unofficially a hearing could come as soon as the District budget is done.

The MSDC letter (seen below) outlined key reasons why B25-124 is critical to improving the health of medicine and District residents. The letter's ask is to hold a hearing on the issue, which the Council did not do in 2022.

Committee Chair CM Christina Henderson is a co-introducer of the legislation and co-introduced the 2022 version of the bill.

MSDC will have more updates in the weeks to come, but now is your chance to get involved. Email hay@msdc.org to get timely updates and tips, and sign-up for MSDC's advocacy session in April.

March 10, 2023

The Honorable Christina Henderson
Chair, Committee on Health
Council of the District of Columbia
1350 Pennsylvania Ave NW
Washington DC 20004

Dear Chair Henderson,

We, the undersigned physicians and healthcare professionals, urge you to hold a hearing on prior authorization legislation before the Council recess this summer.

According to a recent Axios article, 40 states are considering legislation to reform prior authorization practices. The Mayor’s Healthcare Workforce Task Force includes a draft recommendation to reform the practice to prevent healthcare worker burnout and improve retention. Nationally, the movement is to reform a practice that harms patients and hinders care, and the District needs to be a part of this movement.

A recent American Medical Association (AMA) physician survey on prior auth showed that 93% of physicians report care delays because of prior authorization. The same survey showed that physician offices spend 13 hours each week (almost two business days) dedicated to prior auth paperwork.

These delays impact our residents and patients daily, leading many to wait unnecessarily for their treatments or choose to abandon them altogether.

We ask you to hold a hearing on this bill because you and your colleagues need to hear our stories about how prior authorizations negatively impact physicians across the District. We look forward to continuing to share our stories and working with your office to pass this legislation in 2023.

Sincerely,
[80+ physician names withheld for privacy]

Sample of Legislation MSDC Tracked on Opioid and Prescription Policy

 

Access to Biosimilars Amendment Act (B23-430)

What does it do? The bill authorizes licensed pahrmacists to dispense interchangeable biological products and requires notifications to physicians when such interchangeables are dispensed.

MSDC position: MSDC has a position of priority support on this legislation, identifying its passage as one of its highest legislative priorities.

Current status: SUCCESS. The bill was passed by the Council and signed by the Mayor.

Opioid Labeling Amendment Act (B23-535)

What does it do? The bill requires prescription opioid medications to include a statement that the drug is an opioid and opioids may cause dependence, addiction, or overdoes.

MSDC position: MSDC supports the legislation.

Current status: The bill had a hearing before the Committee on Health on July 29, 2020. MSDC leader Dr. Sam Kareff testified for the Medical Society. It passed the Council on November 10 and was signed by the Mayor December 7.

Pre-exposure Prophylaxis Insurance Discrimination Amendment Act (B23-36)

What does it do? The bill prohibits insurance companies from factoring the use of PreP in decisions related to disability, life, or long-term care policies.

MSDC position: MSDC supports this legislation

Current status: The bill was introduced on January 8, 2019 and assigned to the Committee on Business and Economic Development.